Acrivon Therapeutics (NasdaqGM:ACRV) 2026 Conference Transcript

Acrivon Therapeutics (NasdaqGM:ACRV) 2026 Conference February 27, 2026 08:00 AM ET Company ParticipantsAdam Levy - CFO and Head of Investor RelationsBrian Slomovitz - Co-Chair of the Cervical Cancer CommitteeDomenica Lorusso - GOG-Foundation/ENGOT LiaisonMansoor Raza Mirza - CMOPeter Blume-Jensen - CEO, President, and Co-founderRamez N. Eskander - Ovarian Portfolio LeadRobert L. Coleman - CSOAdam LevyGood morning, everyone, and welcome to today's webcast. My name is Adam Levy, and I'm Chief Financial Office ...